Amplifon S.p.A. (AMP) AI Stock Analysis

• Market Cap: €3.41B
• Dividend Yield: 1.92%
• Average Volume (3M): 2.04M
• Price to Earnings (P/E): 27.2
• Beta (1Y): 0.67
• Revenue Growth: 3.83%
• EPS Growth: -21.96%
• Country: IT
• Employees: 11,603
• Sector: Healthcare
• Sector Strength: 40
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.22
• Shares Outstanding: 226,388,630
• 10 Day Avg. Volume: 4,152,735
• 30 Day Avg. Volume: 2,043,639
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €19.81
• Price Target Upside: 31.37% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 9

• Rating: 57 Neutral
• Price Target: €15.50 ▲(2.79% Upside)

Amplifon S.p.A.'s strong financial performance is the most significant positive factor, showing resilience and adaptability. However, technical indicators suggest negative momentum, and the high P/E ratio indicates a potentially expensive valuation, balancing out the financial strengths.

Amplifon S.p.A. Business Overview & Revenue Model

Company Description

Amplifon S.p.A. is a global leader in the distribution of hearing aids and related services, dedicated to improving the quality of life for individuals with hearing loss. Founded in 1950 and headquartered in Milan, Italy, the company operates in over 20 countries, providing innovative hearing solutions, audiological services, and personalized customer care. Amplifon offers a wide range of products, including hearing aids from leading manufacturers and its own branded devices, as well as accessories and assistive listening devices.

How the Company Makes Money

Amplifon generates revenue primarily through the sale of hearing aids and audiological services. The company's key revenue streams include direct sales of hearing aids to customers through its retail network, as well as online sales. Additionally, Amplifon earns income from after-sales services, such as maintenance and repairs, which are essential for customer satisfaction and retention. The company also benefits from partnerships with various manufacturers, which allows it to offer a diverse product range and capitalize on the latest technological advancements in hearing solutions. Furthermore, Amplifon engages in B2B partnerships with healthcare providers and insurance companies, facilitating access to its products and services for a broader audience, thereby contributing to its overall earnings.

Amplifon S.p.A. Financial Statement Overview

Summary

Amplifon S.p.A. demonstrates strong financial health with consistent revenue growth, efficient operations, and robust cash flow management. The balance sheet is well-managed, albeit with moderate leverage, posing some risk. The company is well-positioned in the Medical - Instruments & Supplies industry, showing resilience and adaptability in its financial performance.

Income Statement

Amplifon S.p.A. has demonstrated strong revenue growth over the years, with a consistent increase in total revenue. The TTM (Trailing-Twelve-Months) shows a stable gross profit margin of approximately 56.6%, and a respectable net profit margin of 5.9%. The EBIT and EBITDA margins are 10.4% and 23.2%, respectively, indicating healthy operational efficiency. The company has effectively managed to grow its revenue from 2020 onwards, reflecting a solid upward trajectory.

Balance Sheet

The company's balance sheet reflects a moderately leveraged position with a debt-to-equity ratio of 1.53. The return on equity (ROE) stands at 12.6%, showcasing a decent return for shareholders. The equity ratio is 28.8%, indicating a stable financial structure despite high leverage. While the company is maintaining a solid equity base, the considerable amount of debt suggests potential risks in case of financial downturns.

Cash Flow

Amplifon S.p.A. exhibits strong cash flow management, with consistent operating cash flow generation. The free cash flow to net income ratio is 2.0, indicating efficient conversion of income into cash. The operating cash flow to net income ratio is 3.0, highlighting robust cash flow relative to net income. Although free cash flow growth has been slightly negative recently, the company maintains a healthy cash flow profile, supporting its operations and investments.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.41B	2.26B	2.12B	1.95B	1.56B
Gross Profit	1.36B	548.45M	1.18B	1.11B	863.16M
EBITDA	557.25M	522.01M	513.82M	468.72M	361.67M
Net Income	145.37M	155.14M	178.53M	157.78M	101.00M
Balance Sheet
Total Assets	3.99B	3.69B	3.58B	3.52B	3.23B
Cash, Cash Equivalents and Short-Term Investments	288.85M	194.00M	229.54M	318.44M	554.02M
Total Debt	1.72B	1.52B	1.50B	1.61B	1.56B
Total Liabilities	2.84B	2.59B	2.54B	2.59B	2.43B
Stockholders Equity	1.15B	1.10B	1.04B	925.18M	800.88M
Cash Flow
Free Cash Flow	304.74M	271.89M	342.99M	348.97M	330.63M
Operating Cash Flow	449.35M	413.54M	458.62M	462.37M	391.47M
Investing Cash Flow	-335.10M	-261.48M	-193.78M	-533.61M	-134.28M
Financing Cash Flow	-18.85M	-135.06M	-353.80M	-208.64M	151.52M

Amplifon S.p.A. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 15.08
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AMP, the sentiment is Negative. The current price of 15.08 is below the 20-day moving average (MA) of 17.50, below the 50-day MA of 19.27, and below the 200-day MA of 21.54, indicating a bearish trend. The MACD of -1.36 indicates Positive momentum. The RSI at 26.72 is Positive, neither overbought nor oversold. The STOCH value of 47.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:AMP.

Amplifon S.p.A. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GPI	79 Outperform	€471.81M	4.55		5.11%	16.92%	―
PHN	73 Outperform	€456.94M	27.63		2.14%	17.78%	63.72%
Sector *	63 Neutral	€5.98B	18.21	-2.83%	2.08%	0.47%	-41.00%
AMP	57 Neutral	€3.41B	27.19	11.68%	1.92%	3.83%	-21.96%